| First Published on Clinicaltrials.gov: |
3/6/2007 |
| Status: |
Currently Recruiting |
| ClinicalTrials.gov ID: |
NCT00445172 |
| Sponsor: |
Eisai Limited |
| Purpose: |
The purpose of this study is to investigate the safety and efficacy of long-term E0302 administration in patients with Amyotrophic Lateral Sclerosis (ALS). |
| Phase: |
II/III |
| Treatment Type: |
Injection |
| Trial Type: |
Open label |
| Estimated Enrollment: |
300 |
| Eligibility: |
20 years and older. Both Genders. No healthy volunteers |
| Details: |
One arm study: experimental intramuscular injection E0302 twice a week. |
| Collaborator(s): |
|
| Location(s): |
|
| Primary Investigator: |
Kazunori Saeki, Clinical Development. Neuroscience PCU. Eisai Co.,Ltd. |
| Contact: |
|
| Trial Protocol as Published on Clinicaltrials.gov: |
|
| ALS Forum: |
|